Xiao A, Li X, Wang C, Ye J, et al. Updated survival outcome of regorafenib, ipilimumab, and nivolumab in refractory microsatellite stable non-liver metastatic colorectal cancer: A phase I nonrandomized clinical trial. Eur J Cancer 2024;213:115111.
PMID: 39504677